Ac Immune Sa (ACIU) Directors and Executive Officers - CSIMarket
CSIMarket
 
Ac Immune Sa  (NASDAQ: ACIU)

Ac Immune Sa

Officers & Directors


AC Immune SA was co-founded in 2003 by Andrea Pfeifer, Ph.D., who serves as Chief Executive Officer and Director. Pfeifer led the company through its initial public offering in 2016. She has over 30 years of experience in senior research and development and business leadership roles within the life sciences industry, including serving as Head of the Nestlé Research Centre in Lausanne. Pfeifer holds a Ph.D. in Toxicology from the University of Würzburg, Germany, and is an Honorary Professor at EPFL. Christopher Roberts has been Chief Financial Officer since 2022, having joined AC Immune in 2019. He previously worked for over ten years at Ernst & Young and is a Chartered Accountant with the Institute of Chartered Accountants of Scotland (ICAS). Roberts holds a Bachelor of Science degree in Accounting, Auditing, and Finance from Lancaster University. Piergiorgio Donati joined AC Immune in 2018 as Director of Global Program Management and was appointed Chief Technical Operations Officer in 2020. He has extensive experience in research and development project management as well as chemistry, manufacturing, and controls (CMC) process and product development strategies in senior pharmaceutical roles.

Ac Immune Sa currently has 55 employees.






ACIU Management Effectiveness ACIU Revenue per Employee ACIU Income per Employee


Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.